Venous thromboembolism among gynecologic cancer patients in Zaria

Submitted: February 3, 2024
Accepted: March 25, 2024
Published: November 11, 2024
Abstract Views: 25
PDF: 22
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Cancer is one of the most important acquired risk factors for Venous Thromboembolism (VTE) including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). Patients with active malignancy have up to six-fold increased risk of symptomatic VTE than the general population. The risk of VTE in patients with gynecologic malignancy is especially high because of the nature of the tumor, its pelvic location, associated comorbidities, and systemic chemotherapy.

The objective of this study was to determine other risk factors, incidence, clinical presentation, and immediate outcome of treatment of thromboembolism in patients with gynecologic cancers in Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria.

It was a retrospective cross-sectional descriptive study of gynecologic cancer cases that were diagnosed with VTE while on admission from 2007-2016 in ABUTH.

The overall prevalence of clinical VTE was 2.8% in gynaecologic malignancy. All were DVT. Most cases of DVT were present in ovarian cancers with left-sided preponderance.

There is a need for the provision of modern imaging equipment to facilitate timely and highly sensitive diagnosis of VTE in low-resource settings. The main limitation of this study was the inability to find any confirmed case of PE.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Oranratanaphan S, Termrungruanglert W, Khemapech N. incidence and clinical characteristic of venous thromboembolism in gynecologic oncology patients attending King Chulalongkorn Memorial Hospital over a 10-year period. Asian Pacific Journal of Cancer Prevention. 2015;16:6705-9. DOI: https://doi.org/10.7314/APJCP.2015.16.15.6705
Pookcharoen N, Insin P, Asavapiriyanon S. Risk factor of deep vein thrombosis in gynecologic cancer patients at Rajavithi Hospital. Asian Pacific Journal of Cancer Care. 2018;3:5. DOI: https://doi.org/10.31557/apjcc.2018.3.1.5
Qu H, Li Z, Zhai Z, et al. Predicting of venous thromboembolism for patients undergoing gynecological surgery. Medicine. 2015;94:e1653. DOI: https://doi.org/10.1097/MD.0000000000001653
Ye S, Zhang W, Yang J, et al. Pattern of venous thromboembolism occurrence in gynecologic malignancy. Medicine. 2015;94:e2316. DOI: https://doi.org/10.1097/MD.0000000000002316
Farge D, Deboudeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Journal of Thrombosis and Haemostasis. 2013;11:56-70. DOI: https://doi.org/10.1111/jth.12070
Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic surgery patients. Curr Opin Obstet Gynecol. 1993;5:73-9. DOI: https://doi.org/10.1097/00001703-199302000-00013
Heydari AK, Jafari R, Bojdy A, et al. The role of daily measurement of lower limb circumference in early diagnosis of deep vein thrombosis in the presence of other risk factors in patients admitted to the infectious disease ward of Imam Reza Hospital, Mashhad, 2012-2013. Patient Saf Qual Improv. 2015;3:286-90.
Gomes MP, Deitcher SR. Diagnosis of venous thromboembolic disease in cancer patients. Oncology (Williston Park). 2003;17:126-35.
Qaseem A, Snow V, Barry P, et al. Current diagnosis of venous thromboembolism in primary care_ a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Annals of Internal Medicine. 2007;146:454-8. DOI: https://doi.org/10.7326/0003-4819-146-6-200703200-00013
Liakou CG, Thomakos N Postoperative thromboembolism in gynecologic oncology patients. still a lethal but preventable complication. Br J of Res. 2017;4:31. DOI: https://doi.org/10.21767/2394-3718.100031
Oguntayo OA, Samaila MO. Prevalence of cervical intraepithelial neoplasia in Zaria. Ann Afr Med. 2010;9:194-5. DOI: https://doi.org/10.4103/1596-3519.68351
Rodriguez AO, Wun T, Chew H, et al. VTE in Ovarian Cancer. Gynaecol Oncol. 2007;105:784-90. DOI: https://doi.org/10.1016/j.ygyno.2007.02.024
Narayan A, Eng J, Carmi L, et al. Iliac vein compression as a risk factor for left vs right-sided DVT: case-control study. Radiology. 2012;265:949-57. DOI: https://doi.org/10.1148/radiol.12111580
Vander Meer FJ, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997;78:631-5. DOI: https://doi.org/10.1055/s-0038-1657602
Obalum DC, Giwa SO, Adekoya-Cole TO, et al. Deep vein thrombosis: risk factors and prevention in surgical patients. West African Journal of Medicine. 2009;28:77-82. DOI: https://doi.org/10.4314/wajm.v28i2.48431

How to Cite

Sanusi Gumbi, H., Yahya, A., Tolani, M., Zayyan, M., Mustapha, A., Kolawole, A. O., … Oguntayo, A. (2024). Venous thromboembolism among gynecologic cancer patients in Zaria. Annals of African Medical Research, 7(1). https://doi.org/10.4081/aamr.2024.482